PHARMACYCLICS, INC. (NASDAQ:PCYC)

Bull and Bear

Top Analyst Upgrades and Downgrades: BofA, CA, CBOE, CSX, FedEx, ITT, Potbelly and More

Stocks were looking for direction with minimal losses Friday morning ahead of the revised GDP reading. The one trend that has been set in stone is that investors want to ...
Read Full Story »
Wall Street

Top Analyst Upgrades and Downgrades: Coach, Garmin, Intelsat, Potbelly, SolarCity, Valero and More

Stocks were again seeking direction on Thursday morning after recently hitting new highs again. If there is one trend that keeps being proven it is that investors will buy stocks ...
Read Full Story »
Biotechnology word cloud

Wells Fargo’s Top Biotech Stocks for 2015

Looking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo ...
Read Full Story »
95992888

Analyst’s 5 Top Momentum Stocks for 2015 With Huge Upside Potential

Momentum investors are a brave breed, and depending on market conditions, sometimes a rare one. They have enjoyed a nice run since the market lows of 2009 and could be poised ...
Read Full Story »
buy sell

11 Very Popular Stocks Now Valued Over 50 Times Earnings

2014 has been another great year for stocks, with gains of more than 10% in the Dow Jones Industrial Average and in the S&P 500 Index. That being said, some ...
Read Full Story »
Biotechnology word cloud

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

The firms we cover on Wall Street are sometimes like covering the major sports teams. Analysts are like the top players and tend to move around as their career strengths ...
Read Full Story »
Biotechnology word cloud

4 Top Biotechs Expected to Beat Earnings Expectations

With earning season just starting to be in full gear, everybody on Wall Street is looking for the earnings angle, and it seems like almost every firm we cover here ...
Read Full Story »
95992888

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

After two years of dominant performance in 2012 and 2013, the biotech rally hit a wall in late February, and the top stocks got absolutely hammered. Immediately, the bears jumped ...
Read Full Story »
health care

Analyst Cancer and Biotech Stock Picks From ASCO

As the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest ...
Read Full Story »
Biotechnology word cloud

Who Bucked the Short Interest Trend in Biotech Stocks?

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many ...
Read Full Story »
pandora

Credit Suisse Sees These Six Stocks as Momentum Traps

Momentum stocks are the greatest things in the world when the market goes up like it did last year. There is always somebody willing to buy the stocks high under ...
Read Full Story »
Morgan Stanley logo

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Like many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley taking a closer look at the top names. The firm initiated coverage of ...
Read Full Story »
Biotechnology word cloud

Short Sellers Find Renewed Interest in Biotech Stocks

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. After retreating from many of these stocks in the previous two periods, short sellers returned ...
Read Full Story »
Biotechnology word cloud

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers shied away from these stocks in late January. The largest ...
Read Full Story »
yoga

Ten Top Growth Stock Ideas for 2014 From Baird

Many of the top Wall Street firms released their top 2014 ideas in the month of December. This is the first full trading week of 2014, and many firms are ...
Read Full Story »